Experiential HIV Testing Increasing Testing Related Knowledge and Practice, and Reduce Stigma Toward HIV of Nurses.

Sponsor
National Taiwan University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05615935
Collaborator
(none)
60
1
2
3.6
16.5

Study Details

Study Description

Brief Summary

This is a randomized controlled trial design. The investigators plan to recruit about 60 to 70 emergency department nurses from a medical center in Taipei, Taiwan. After completing the paper consent form, these nurses will be randomly assigned to 2 groups, which are a control group and an experimental group. The pre-test includes the demographic data sheet, HIV testing related knowledge and practice scale, and The Health Care Provider HIV/ AIDS Stigma Scale (HPASS). All nurses will receive a learning material when they finish the pre-test. In addition, the experimental group will be provided a real HIV testing and counselling by a researcher. The post-test will be finished one month later of pre-test in the control group, and one month later while the intervention completed in the experimental group. The semi-structural interview will be performed to the experimental group to collect and analyze their opinion toward the experiential HIV testing.

Condition or Disease Intervention/Treatment Phase
  • Other: Experiential HIV Testing
N/A

Detailed Description

This project aims to develop an intervention of "experiential HIV testing" and to verify the following effects on emergency nurses: (1) Improve HIV testing related knowledge and practice; (2) Reduce HIV-related stigma; (3) Find out the possible demographic factors that might affect the effectiveness of experiential HIV Testing. During the intervention, nurses can directly participate in the whole process of anonymous HIV testing in the role of who need to be screened, and pre- and post-testing counselling accompanied the education and discussion will also be provided to them by a researcher. Through the above-mentioned measures, the knowledge and practices related to the HIV testing could be improved, and the stigma attitude toward HIV could be reduced through the self-reflection on the testing process.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Other
Official Title:
The Effects of Experiential HIV Testing to Improve Knowledge and Practice, and Reduce Stigma Toward HIV of Emergency Department Nurses
Anticipated Study Start Date :
Nov 1, 2022
Anticipated Primary Completion Date :
Dec 14, 2022
Anticipated Study Completion Date :
Feb 20, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Get a learning material and a experiential HIV Testing

These participants in the experimental group will be provided a learning material about HIV testing, then an experiential HIV Testing, which includes HIV testing and counselling, education and discussion, and a post-test interviews will be provided.

Other: Experiential HIV Testing
The content of experiential HIV Testing includes HIV testing, counselling, and education and discussion.

No Intervention: Get a learning material only

These participants in the control group will be provided a learning material about HIV testing only. After the post-test, the experiential HIV Testing will be provided to them.

Outcome Measures

Primary Outcome Measures

  1. HIV testing related knowledge and practice [one month later]

    A self-development scale, "HIV testing related knowledge and practice scale", is applied to measure the HIV testing related knowledge and practice. There are twenty-eight questions, including True-False questions and multiple-choice questions. One correct answer could get one point, and the total score is 28 points. Higher scores mean a better outcome (having more HIV testing related knowledge and practice) of the participants.

  2. HIV related stigma [one month later]

    The questionnaire of "The Healthcare Provider HIV/AIDS Stigma Scale (HPASS)" will be used to measure this outcome. There are thirty questions, each question is scaled from one to six points. The minimum value of the total score is 30 points; the maximum value of the total score is 180 points. Higher scores mean a worse outcome, more stigma toward people living with HIV of the participant.

Secondary Outcome Measures

  1. The demographic factors which affect the effectiveness of experiential HIV testing [one month later]

    Two-way ANOVA(mixed design) will be used to analyze this outcome.

Other Outcome Measures

  1. Qualitative analysis of post-test interview in experimental group. [one month later]

    In order to qualitatively analyses and understands the participants' opinions of the experiential learning, four open-ended questions are applied to the interview in the post-test period. The four questions are: "After experiencing HIV testing, what changes in your mind while waiting for the test results?"; "After experiencing HIV testing, does it make you curious about HIV or want to know more about HIV-related knowledge?"; "After experiencing HIV testing, what changes have you felt towards HIV-related stigma?"; "How and what is this experiential learning method different from traditional lecture class?"

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • have registered nurse license and do clinical care in emergency department
Exclusion Criteria:
  • have registered nurse license but doesn't do clinical care, likes head nurse.

  • do clinical care in emergency department but doesn't have registered nurse license, like volunteers or assistant nurse.

  • have experienced non-occupational HIV testing.

  • had been a nurse in HIV/AIDS-focus ward or HIV/AIDS case manager.

Contacts and Locations

Locations

Site City State Country Postal Code
1 School of Nursing of National Taiwan University Taipei Taiwan 100

Sponsors and Collaborators

  • National Taiwan University

Investigators

  • Principal Investigator: CHENG-RU HE, Bachelor, National Taiwan University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Piao-Yi Chiou, Associate Professor, National Taiwan University
ClinicalTrials.gov Identifier:
NCT05615935
Other Study ID Numbers:
  • 202209065RINA
First Posted:
Nov 14, 2022
Last Update Posted:
Nov 14, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Piao-Yi Chiou, Associate Professor, National Taiwan University

Study Results

No Results Posted as of Nov 14, 2022